Moolec Science (MLECW) Restructuring Costs (2022 - 2024)
Moolec Science (MLECW) posted Restructuring Costs of -$956846.0 for Q4 2024, up 39.76% sequentially from -$1.6 million in Q3 2024, and up 43.23% YoY from -$668068.9 in Q1 2024.
Moolec Science (MLECW) Restructuring Costs (2022 - 2024) Analysis & Trends
Moolec Science has reported Restructuring Costs for 3 years, with the latest figure at -$956846.0 in Q4 2024.
- Quarterly Restructuring Costs rose 43.23% year-over-year to -$956846.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$6.5 million (down 149.41% YoY) and the FY2024 annual result came in at -$7.5 million, down 112.81% from the prior year.
- Restructuring Costs grew to -$956846.0 in Q4 2024 per MLECW's latest filing, from -$1.6 million in the prior quarter.
- Over five years, Restructuring Costs peaked at $934941.0 in Q1 2023 and troughed at -$4.5 million in Q4 2022.
- A 3-year average of -$1.4 million and a median of -$1.6 million in 2024 frame the typical range for Restructuring Costs.
- The widest YoY moves for Restructuring Costs: up 399.95% in 2023, down 492.38% in 2023.
- Over 3 years, Restructuring Costs stood at -$4.5 million in 2022, then soared by 62.3% to -$1.7 million in 2023, then surged by 43.23% to -$956846.0 in 2024.
- According to Business Quant data, Restructuring Costs over the past three periods registered -$956846.0, -$1.6 million, and -$2.4 million for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Moolec Science | 8,617.72 | -1.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -956,846.00 |
| Sep 30, 2024 | -1.59 Mn |
| Jun 30, 2024 | -2.36 Mn |
| Mar 31, 2024 | -1.61 Mn |
| Dec 31, 2023 | -1.69 Mn |
| Sep 30, 2023 | -1.86 Mn |
| Mar 31, 2023 | 934,941.00 |
| Dec 31, 2022 | -4.47 Mn |
| Sep 30, 2022 | -314,565.00 |
| Jun 30, 2022 | -1.01 Mn |
| Mar 31, 2022 | -311,697.00 |